Elevated levels of FMR1 mRNA carrier males: A new mechanism of involvement in the fragile-X syndrome

American Journal of Human Genetics

Volumn 66, Issue 1, 2000, Pages 6-15

  Tassone, Flora ^a   Hagerman, Randi J ^b,c   Taylor, Annette K ^d   Gane, Louise W ^c   Godfrey, Tony E ^e   Hagerman, Paul J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b The Children's Hospital ^*  (United States)

^c Children's Hospital   (United States)

^d Kimball Genetics Inc   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE; FRAGILE X SYNDROME; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HETEROZYGOTE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MALE; MENTAL RETARDATION MALFORMATION SYNDROME; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; TRINUCLEOTIDE REPEAT;

EID: 0033940157     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302720     Document Type: Article

References (40)

1. Allingham-Hawkins DJ, Bahul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, et al (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study - preliminary data. Am J Med Genet 83:322-325
2. Baeyens DA, Cornett LE (1993) Transcriptional and posrtranscriptional regulation of hepatic beta 2-adrenergic receptor gene expression during development. J Cell Physiol 157:70-76
3. Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, et al (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575
4. de Vries BBA, Jansen CCAM, Duits AA, Verheij C, Willemsen R, van Hemel JO, van den Ouweland AMW, et al (1996) Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J Med Genet 33:1007-1010
5. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340
6. Dorn MB, Mazzocco MMM, Hagerman RJ (1994) Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry 33:256-264
7. Feng Y, Lakkis L, Devys D, Warren ST (1995a) Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet 56:106-113
8. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST (1995b) Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734
9. Franke P, Leboyer M, Gansicke M, Weiffenbach O, Biancalana V, Cornillet-Lefebre P, Croquette MF, et al (1998) Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 80:113-127
10. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, et al (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058
11. Gibson UE, Heid CA, Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6:995-1001
12. Gu Yanghong, Lugenbeel KA, Vockley JG, Grody WW, Nelson DL (1994) A de novo deletion in FMR1 in a patient with developmental delay. Hum Mol Genet 3:1705-1706
13. Hagerman RJ (1996) Physical and behavioral phenotype. In: Hagerman RJ, Cronister AC (eds) Fragile X syndrome: diagnosis, treatment, and research, 2d ed. Johns Hopkins University Press, Baltimore, pp 3-87
14. -(1999) Fragile X syndrome. In: Neurodevelopmental disorders: diagnosis and treatment. Oxford University Press, Oxford, pp 61-132
15. Hagerman RJ, Staley LW, O'Conner R, Lugenbeel K, Nelson D, McLean SD, Taylor AK (1996) Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97:122-126
16. Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986-994
17. Hmadcha A, De Diego Y, Pintado E (1998) Assessment of FMR1 expression by reverse transcriptase-polymerase chain reaction of KH domains. J Lab Clin Med 131:170-173
18. Kaufmann WE, Abrams MT, Chen W, Reiss AL (1999) Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome. Am J Med Genet 83:286-295
19. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K (1995) Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4: 357-362
20. Loesch DZ, Hay DA, Mulley J (1994) Transmitting males and carrier females in fragile X - revisited. Am J Med Genet 51: 392-399
21. Loesch DZ, Hay DA, Sutherland GR, Halliday J, Judge C, Webb GC (1987) Phenotypic variation in male-transmitted fragile X: genetic inferences. Am J Med Genet 27:401-417
22. Mazzocco MM, Pennington BF, Hagerman RJ (1993) The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr 14:328-335
23. Murray A, Webb J, Grimley S, Conway G, Jacobs P (1998) Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35:637-640
24. Oberlè I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Bouè J, et al (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102
25. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822
26. Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H (1993) Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet 52:884-894
27. Riddle JE, Cheema A, Sobesky WE, Gardner SC, Taylor AK, Pennington BF, Hagerman RJ (1998) Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard 102:590-601
28. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, et al (1994) A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet 55:225-237
29. Sabourin LA, Mahadevan MS, Narang M, Lee DSC, Surh LC, Korneluk RG (1993) Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat Genet 4: 233-238
30. Smeets HJM, Smits APT, Verheij CE, Theelen JPG, Willemsen R, van de Burgt I, Hoogeveen AT, et al (1995) Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4:2103-2108
31. Smits A, Smeets D, Hamel B, Dreesen J, de Haan A, van Oost B (1994) Prediction of mental status in carriers of the fragile X mutation using CGG repeat length. Am J Med Genet 51: 497-500
32. Steyaert J, Borghgraef M, Legius E, Fryns J-P (1996) Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene. Am J Med Genet 64:274-277
33. Tassone F, Hagerman RJ, Ilke DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, et al (1999) FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84:250-261
34. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Wood S, Gane LW, Hagerman PJ. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet (in press)
35. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, et al (1994) Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 271:507-514
36. Turner G, Robinson H, Wake S, Martin N (1994) Dizygous twinning and premature menopause in fragile X syndrome. Lancet 344:1500
37. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, et al (1993) Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724
38. Waring JD, Korneluk RG (1998) Genetic studies of the myotonic dystrophy CTG repeat. In: Wells RD, Warren ST (eds) Genetic instabilities and hereditary neurological diseases. Academic Press, San Diego
39. Willemsen R, Mohkamsing S, de Vries BBA, Devys D, van den Ouweland A, Mandel J-L, Galjaard H, et al (1995) Rapid antibody test for fragile X syndrome. Lancet 345:1147-1148
40. Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, de Haan A, de Vries B, van den Ouweland A, et al (1997) Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 99:308-311